Literature DB >> 17884977

A role of Wnt/beta-catenin signals in hepatic fate specification of human umbilical cord blood-derived mesenchymal stem cells.

Yoko Yoshida1, Takashi Shimomura, Tomohiko Sakabe, Kyoko Ishii, Kazue Gonda, Saori Matsuoka, Yumi Watanabe, Kazuko Takubo, Hiroyuki Tsuchiya, Yoshiko Hoshikawa, Akihiro Kurimasa, Ichiro Hisatome, Taro Uyama, Masanori Terai, Akihiro Umezawa, Goshi Shiota.   

Abstract

Human umbilical cord blood-derived mesenchymal stem cells (UCBMSCs) are expected to be an excellent source of cells for transplantation. In addition, the stem cell plasticity of human UCBMSCs, which can transdifferentiate into hepatocytes, has been reported. However, the mechanisms involved remain to be clarified. To identify the genes and/or signals that are important in specifying the hepatic fate of human UCBMSCs, we analyzed gene expression profiles during the hepatic differentiation of UCBMSCs with human telomerase reverse transcriptase, UCBMSCs immortalized by infection with a retrovirus carrying telomerase reverse transcriptase, but whose differentiation potential remains unchanged. Efficient differentiation was induced by 5-azacytidine (5-aza)/hepatocyte growth factor (HGF)/oncostatin M (OSM)/fibroblast growth factor 2 (FGF2) treatment in terms of function as well as protein expression: 2.5-fold increase in albumin, 4-fold increase in CCAAT enhancer-binding protein alpha, 1.5-fold increase in cytochrome p450 1A1/2, and 8-fold increase in periodic acid-Schiff staining. Consequently, we found that the expression of Wnt/beta-catenin-related genes downregulated, and the translocation of beta-catenin was observed along the cell membrane and in the cytoplasm, although some beta-catenin was still in the nucleus. Downregulation of Wnt/beta-catenin signals in the cells by Fz8-small interference RNA treatment, which was analyzed with a Tcf4 promoter-luciferase assay, resulted in similar hepatic differentiation to that observed with 5-azacytidine/HGF/OSM/FGF2. In addition, the subcellular distribution of beta-catenin was similar to that of cells treated with 5-azacytidine/HGF/OSM/FGF2. In conclusion, the suppression of Wnt/beta-catenin signaling induced the hepatic differentiation of UCBMSCs, suggesting that Wnt/beta-catenin signals play an important role in the hepatic fate specification of human UCBMSCs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17884977     DOI: 10.1152/ajpgi.00187.2007

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  19 in total

1.  Wnt/Beta-Catenin Signal Inhibitor HC-1 Sensitizes Oral Squamous Cell Carcinoma Cells to 5-Fluorouracil through Reduction of CD44-Positive Population.

Authors:  Satoshi Yokogi; Toshiaki Tsubota; Keita Kanki; Junya Azumi; Noriko Itaba; Hiroyuki Oka; Minoru Morimoto; Kazuo Ryoke; Goshi Shiota
Journal:  Yonago Acta Med       Date:  2016-06-29       Impact factor: 1.641

Review 2.  Current status and future prospects of mesenchymal stem cell therapy for liver fibrosis.

Authors:  Yang Guo; Bo Chen; Li-Jun Chen; Chun-Feng Zhang; Charlie Xiang
Journal:  J Zhejiang Univ Sci B       Date:  2016 Nov.       Impact factor: 3.066

3.  Extracellular regulated protein kinases 1/2 phosphorylation is required for hepatic differentiation of human umbilical cord-derived mesenchymal stem cells.

Authors:  Yongmin Yan; Yuan Zhu; Feng Sun; Bin Zhang; Limin Li; Zixuan Sun; Wei Li; Hui Qian; Wei Zhu; Wenrong Xu
Journal:  Exp Biol Med (Maywood)       Date:  2015-01-08

Review 4.  Role of Wnt/β-catenin signaling in liver metabolism and cancer.

Authors:  Satdarshan Pal Singh Monga
Journal:  Int J Biochem Cell Biol       Date:  2009-09-09       Impact factor: 5.085

5.  Nuclear translocation of β-catenin during mesenchymal stem cells differentiation into hepatocytes is associated with a tumoral phenotype.

Authors:  Carmen Herencia; Julio M Martínez-Moreno; Concepción Herrera; Fernando Corrales; Raquel Santiago-Mora; Isabel Espejo; Monserrat Barco; Yolanda Almadén; Manuel de la Mata; Antonio Rodríguez-Ariza; Juan R Muñoz-Castañeda
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

6.  Conditioned Media from Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Inhibits Melanogenesis by Promoting Proteasomal Degradation of MITF.

Authors:  Eun Sung Kim; Hong Bae Jeon; Hoon Lim; Ji Hyun Shin; So Jung Park; Yoon Kyung Jo; Wonil Oh; Yoon Sun Yang; Dong-Hyung Cho; Ju-Yeon Kim
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

7.  Induction of highly functional hepatocytes from human umbilical cord mesenchymal stem cells by HNF4α transduction.

Authors:  Hualian Hang; Yabin Yu; Ning Wu; Qingfeng Huang; Qiang Xia; Jianmin Bian
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

Review 8.  In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art.

Authors:  Sarah Snykers; Joery De Kock; Vera Rogiers; Tamara Vanhaecke
Journal:  Stem Cells       Date:  2009-03       Impact factor: 6.277

9.  Identification of a Novel Deactivating Small-Molecule Compound for Fibrogenic Hepatic Stellate Cells.

Authors:  Takuki Sakaguchi; Yohei Kono; Noriko Itaba; Minoru Morimoto; Hajime Isomoto; Goshi Shiota
Journal:  Yonago Acta Med       Date:  2020-02-20       Impact factor: 1.641

Review 10.  In Vitro and In Vivo Hepatic Differentiation of Adult Somatic Stem Cells and Extraembryonic Stem Cells for Treating End Stage Liver Diseases.

Authors:  Chenxia Hu; Lanjuan Li
Journal:  Stem Cells Int       Date:  2015-08-05       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.